Surapol Suwanagool

712 total citations
40 papers, 569 citations indexed

About

Surapol Suwanagool is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Surapol Suwanagool has authored 40 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 19 papers in Epidemiology and 12 papers in Virology. Recurrent topics in Surapol Suwanagool's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Surapol Suwanagool is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Surapol Suwanagool collaborates with scholars based in Thailand, United States and Australia. Surapol Suwanagool's co-authors include Winai Ratanasuwan, Thanomsak Anekthananon, Winai Ratanasuwan, Surapee Tiengrim, Robert M. Chanock, Robert F. Betts, R. Gordon Douglas, David R. Nalin, Brian R. Murphy and Myron M. Levine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Infection and Immunity.

In The Last Decade

Surapol Suwanagool

38 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Surapol Suwanagool Thailand 13 321 283 136 65 56 40 569
Faouzi Souala France 10 206 0.6× 240 0.8× 199 1.5× 48 0.7× 34 0.6× 19 424
J Frottier France 14 412 1.3× 326 1.2× 71 0.5× 32 0.5× 37 0.7× 78 667
Steve R. Nesheim United States 10 255 0.8× 339 1.2× 186 1.4× 50 0.8× 17 0.3× 11 506
Wing-Wai Wong Taiwan 12 193 0.6× 339 1.2× 195 1.4× 46 0.7× 36 0.6× 19 668
Roberto Novati Italy 15 367 1.1× 186 0.7× 164 1.2× 74 1.1× 204 3.6× 24 716
T C Quinn United States 11 321 1.0× 302 1.1× 185 1.4× 64 1.0× 55 1.0× 15 634
Timothy Burgess United States 17 354 1.1× 327 1.2× 87 0.6× 133 2.0× 63 1.1× 51 803
Jean‐Elie Malkin France 14 547 1.7× 319 1.1× 178 1.3× 65 1.0× 36 0.6× 45 863
Harrison C. Stetler United States 15 383 1.2× 349 1.2× 76 0.6× 55 0.8× 119 2.1× 23 709
G Sridharan India 17 274 0.9× 373 1.3× 190 1.4× 31 0.5× 83 1.5× 54 655

Countries citing papers authored by Surapol Suwanagool

Since Specialization
Citations

This map shows the geographic impact of Surapol Suwanagool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surapol Suwanagool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surapol Suwanagool more than expected).

Fields of papers citing papers by Surapol Suwanagool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surapol Suwanagool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surapol Suwanagool. The network helps show where Surapol Suwanagool may publish in the future.

Co-authorship network of co-authors of Surapol Suwanagool

This figure shows the co-authorship network connecting the top 25 collaborators of Surapol Suwanagool. A scholar is included among the top collaborators of Surapol Suwanagool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surapol Suwanagool. Surapol Suwanagool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sangsiriwut, Kantima, et al.. (2020). High Performance Liquid Chromatographic Assay for the Determination of Protease Inhibitors (PIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in Human Plasma. SHILAP Revista de lepidopterología.
2.
Ratanasuwan, Winai, Surapol Suwanagool, Anna Lena Lopez, et al.. (2015). Peru-15 (Choleragarde®), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand. Vaccine. 33(38). 4820–4826. 5 indexed citations
3.
Nelson, Kenrad E., et al.. (2007). Body Shape and Metabolic Abnormalities in Thai HIV-Infected Patients. AIDS Research and Human Retroviruses. 23(11). 1314–1321. 10 indexed citations
4.
Wasi, Chantapong, et al.. (2006). Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change. Virology. 347(2). 372–378. 6 indexed citations
5.
6.
Anekthananon, Thanomsak, et al.. (2004). HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.. PubMed. 87(2). 173–9. 20 indexed citations
7.
Anekthananon, Thanomsak, et al.. (2004). Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study.. PubMed. 87(7). 760–7. 38 indexed citations
8.
Onlamoon, Nattawat, Surada Lerdwana, Winai Ratanasuwan, et al.. (2003). Intracellular production of type I and type II cytokines during HIV-1 progression in Thai patients.. PubMed. 21(1). 43–8. 3 indexed citations
9.
Shigeta, Akiko, et al.. (2002). Epidemiological correlation between chromium content in gallstones and cholesterol in blood.. PubMed. 85(2). 183–94. 3 indexed citations
10.
Ungsedhapand, Chaiwat, Eugène Kroon, Surapol Suwanagool, et al.. (2001). A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(2). 116–123. 11 indexed citations
11.
Waywa, Duangdao, Surapee Tiengrim, Surapol Suwanagool, et al.. (2001). Protozoan enteric infection in AIDS related diarrhea in Thailand.. PubMed. 32 Suppl 2. 151–5. 47 indexed citations
12.
Ruxrungtham, Kiat, Surapol Suwanagool, Jorge A. Tavel, et al.. (2000). A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand. AIDS. 14(16). 2509–2513. 30 indexed citations
13.
Phanuphak, Praphan, M. Lindsay Grayson, Sunee Sirivichayakul, et al.. (2000). A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South‐East Asia. Australian and New Zealand Journal of Medicine. 30(1). 11–20. 6 indexed citations
14.
Chuchottaworn, Charoen, et al.. (1999). Prevalence of disseminated Mycobacterium avium complex infection in Thai AIDS patients.. PubMed. 82(7). 643–7. 6 indexed citations
15.
Chongkolwatana, Cheerasook, et al.. (1998). Primary cryptococcal infection of the larynx in a patient with AIDS: a case report.. PubMed. 81(6). 462–7. 14 indexed citations
16.
Assantachai, Prasert, et al.. (1997). Urinary tract infection in the elderly: a clinical study.. PubMed. 80(12). 753–9. 2 indexed citations
17.
Suwanagool, Surapol, et al.. (1995). Seroprevalence of anti-HCV among HIV-infected persons and general population.. PubMed. 78(11). 611–7. 10 indexed citations
18.
Pattanapanyasat, Kovit, et al.. (1994). Flow cytometric three-color determination of CD4 T-lymphocytes on blood specimens from AIDS patients who have a large number of contaminating non-lymphocytes.. PubMed. 12(2). 105–9. 3 indexed citations
19.
Suwanagool, Surapol. (1983). Pathogenicity of Eikenella corrodens in Humans. Archives of Internal Medicine. 143(12). 2265–2265. 49 indexed citations
20.
Murphy, Brian R., R. Gordon Douglas, Robert F. Betts, et al.. (1980). Evaluation of Influenza A/Hong Kong/123/77 (H1N1) ts -1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers. Infection and Immunity. 29(2). 348–355. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faouzi Souala Breakdown of academic impact, for papers by J Frottier Breakdown of academic impact, for papers by Steve R. Nesheim Breakdown of academic impact, for papers by Wing-Wai Wong Breakdown of academic impact, for papers by Roberto Novati Breakdown of academic impact, for papers by T C Quinn Breakdown of academic impact, for papers by Timothy Burgess Breakdown of academic impact, for papers by Jean‐Elie Malkin Breakdown of academic impact, for papers by Harrison C. Stetler Breakdown of academic impact, for papers by G Sridharan
Rankless by CCL
2026